Online inquiry

IVTScrip™ mRNA-Human ACTR2, (Cap 1, 5-Methyl-CTP & Pseudo-UTP, 30 nt-poly(A))   (CAT#: GTTS-WK14271MR)

This product GTTS-WK14271MR is a type of mRNA having 120 nt poly(A) tail and modified with Cap 0 & 5-Methyl-CTP & Pseudo-UTP. It ecodes the ACTR2 protein. This product can be used in Regulatory T (Treg) cell-related researches.
Specifications
Product type mRNA
Modified bases 5-Methyl-CTP & Pseudo-UTP
5' Cap Cap 1
Species Human
RefSeq NM_001005386.3
Applications Gene therapy research
Format Powder
Quantity 100 µg
Purification Chromatography
Target Gene
Gene ID 10097
UniProt ID P61160
Download
Download resources about mRNA therapeutics development to boost your research.
CUSTOMER REVIEWS and Q&As

There are currently no Customer reviews or questions for IVTScrip™ mRNA-Human ACTR2, (Cap 1, 5-Methyl-CTP & Pseudo-UTP, 30 nt-poly(A)) (GTTS-WK14271MR). Click the button above to contact us or submit your feedback about this product.
See other products
CAT Product Name Product Type CDs
GTTS-WK25856MR IVTScrip™ mRNA-Human ARAP1, (Cap 1, 5-Methoxy-UTP, 120 nt-poly(A)) mRNA ARAP1
GTTS-WK19102MR IVTScrip™ mRNA-Human ANKRD16, (Cap 1, 2-Thio-UTP, 120 nt-poly(A)) mRNA ANKRD16
GTTS-WK19724MR IVTScrip™ mRNA-Human ANKRD39, (Cap 1, 5-Methyl-CTP & Pseudo-UTP, 120 nt-poly(A)) mRNA ANKRD39
GTTS-WK14966MR IVTScrip™ mRNA-Human ANXA8, (Cap 0, N1-Methylpseudo-UTP, 120 nt-poly(A)) mRNA ANXA8
GTTS-WK19424MR IVTScrip™ mRNA-Human ANKRD39, (Cap 1, 5-Methyl-CTP, 120 nt-poly(A)) mRNA ANKRD39
GTTS-WK23262MR IVTScrip™ mRNA-Human ARNT2, (Cap 0, 5-Methyl-CTP & Pseudo-UTP, 120 nt-poly(A)) mRNA ARNT2
GTTS-WK23214MR IVTScrip™ mRNA-Human ARHGEF26, (Cap 0, 5-Methyl-CTP & Pseudo-UTP, 120 nt-poly(A)) mRNA ARHGEF26
GTTS-WK26570MR IVTScrip™ mRNA-Human ARPC4-TTLL3, (Cap 1, 5-Methyl-CTP, 120 nt-poly(A)) mRNA ARPC4-TTLL3
All products and services are For Research Use Only and CANNOT be used in the treatment or diagnosis of disease.
webinar

EABR Nanoparticles as a Platform Technology for Hybrid mRNA Vaccine Development

November 20th, 2024, 2 PM–3 PM EST

REGISTER NOW